85 related articles for article (PubMed ID: 7570051)
1. Single-agent oral granisetron for the prevention of acute cisplatin-induced emesis: a double-blind, randomized comparison with granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone.
Heron JF
Semin Oncol; 1995 Aug; 22(4 Suppl 10):24-30. PubMed ID: 7570051
[No Abstract] [Full Text] [Related]
2. Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.
Numbenjapon T; Sriswasdi C; Mongkonsritragoon W; Leelasiri A; Prayoonwiwat W
J Med Assoc Thai; 2002 Nov; 85(11):1156-63. PubMed ID: 12546311
[TBL] [Abstract][Full Text] [Related]
3. Oral granisetron alone and in combination with dexamethasone: a double-blind randomized comparison against high-dose metoclopramide plus dexamethasone in prevention of cisplatin-induced emesis. The Granisetron Study Group.
Heron JF; Goedhals L; Jordaan JP; Cunningham J; Cedar E
Ann Oncol; 1994 Sep; 5(7):579-4. PubMed ID: 7993831
[TBL] [Abstract][Full Text] [Related]
4. A double-blind randomized study comparing intramuscular (i.m.) granisetron with i.m. granisetron plus dexamethasone in the prevention of delayed emesis induced by cisplatin. The Italian Multicenter Study Group.
Anticancer Drugs; 1999 Jun; 10(5):465-70. PubMed ID: 10477166
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy.
Chiou TJ; Tzeng WF; Wang WS; Yen CC; Fan FS; Liu JH; Chen PM
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):729-36. PubMed ID: 11076429
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of granisetron alone and granisetron plus dexamethasone or hydroxyzine hydrochloride for the prevention of nausea and vomiting during chemotherapy including cisplatin].
Tsukuda M; Kohno H; Enomoto H; Kawai S; Yago T; Matsuda H; Ikema Y; Makino Y; Kubota A; Furukawa M
Gan To Kagaku Ryoho; 1995 Sep; 22(10):1377-82. PubMed ID: 7668873
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of granisetron compared with high-dose metoclopramide plus dexamethasone in patients receiving high-dose cisplatin in a single-blind study. The Granisetron Study Group.
Chevallier B
Eur J Cancer; 1990; 26 Suppl 1():S33-6. PubMed ID: 2169784
[TBL] [Abstract][Full Text] [Related]
8. Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial.
Gebbia V; Testa A; Valenza R; Cannata G; Tirrito ML; Gebbia N
Cancer; 1995 Nov; 76(10):1821-8. PubMed ID: 8625054
[TBL] [Abstract][Full Text] [Related]
9. A randomized cross-over study of high-dose metoclopramide plus dexamethasone versus granisetron plus dexamethasone in patients receiving chemotherapy with high-dose cisplatin.
Ohmatsu H; Eguchi K; Shinkai T; Tamura T; Ohe Y; Nisio M; Kunikane H; Arioka H; Karato A; Nakashima H
Jpn J Cancer Res; 1994 Nov; 85(11):1151-8. PubMed ID: 7829401
[TBL] [Abstract][Full Text] [Related]
10. Prevention of cisplatin-induced emesis by the oral neurokinin-1 antagonist, MK-869, in combination with granisetron and dexamethasone or with dexamethasone alone.
Campos D; Pereira JR; Reinhardt RR; Carracedo C; Poli S; Vogel C; Martinez-Cedillo J; Erazo A; Wittreich J; Eriksson LO; Carides AD; Gertz BJ
J Clin Oncol; 2001 Mar; 19(6):1759-67. PubMed ID: 11251007
[TBL] [Abstract][Full Text] [Related]
11. [Randomized controlled study of high-dose metoclopramide and dexamethasone in the prevention of CDDP-induced emesis].
Umehara H; Sawamura N; Takahashi S; Kusano H; Yokoyama S; Suemasu K
Gan To Kagaku Ryoho; 1986 May; 13(5):1996-8. PubMed ID: 3010886
[No Abstract] [Full Text] [Related]
12. [Combination effect of granisetron plus corticosteroid for prevention of cisplatin-induced emesis: a cross-over study comparing methylprednisolone and dexamethasone].
Tanaka K; Sekine M; Serikawa T; Sanada H; Shichiri K; Fujimori R
Gan To Kagaku Ryoho; 1998 May; 25(6):907-13. PubMed ID: 9617330
[TBL] [Abstract][Full Text] [Related]
13. [A comparative study of the effects of granisetron alone and a combination of granisetron plus steroids on CDDP-based combination chemotherapy-induced emesis--outcomes of a multicenter randomized comparative study using the central registration method. Nara Medical University Kytril Study Group].
Ozono S; Okajima E; Hirao YK; Natsume O; Kaneko Y; Ohara S; Tabata S; Watanabe S; Aoyama H; Sasaki K; Matsuki H; Takashima K; Maruyama Y; Yoshikawa M; Yamada K; Momose H; Hiramatsu T; Hayashi Y; Babaya K; Shiomi T
Gan To Kagaku Ryoho; 1997 Feb; 24(3):349-56. PubMed ID: 9051139
[TBL] [Abstract][Full Text] [Related]
14. Improved control of high-dose-cisplatin-induced acute emesis with the addition of prochlorperazine to granisetron/dexamethasone.
Hesketh PJ; Gandara DR; Hesketh AM; Edelman M; Webber LM; McManus M; Hainsworth JD
Cancer J Sci Am; 1997; 3(3):180-3. PubMed ID: 9161784
[TBL] [Abstract][Full Text] [Related]
15. Comparison of ramosetron and granisetron for the prevention of acute and delayed emesis in Cisplatin-based chemotherapy: a randomized controlled trial.
Cheirsilpa A; Sinthusake T; Songsakkaesorn A; Visawaprasit S; Chulaka K; Changkuingdee N
Jpn J Clin Oncol; 2005 Dec; 35(12):695-9. PubMed ID: 16319109
[TBL] [Abstract][Full Text] [Related]
16. Comparative crossover trial of two intravenous doses of granisetron (1 mg vs 3 mg) + dexamethasone in the prevention of acute cis-platinum-induced emesis.
Martoni A; Piana E; Strocchi E; Angelelli B; Guaraldi M; Zamagni C; Camaggi CM; Pannuti F
Anticancer Res; 1998; 18(4B):2799-803. PubMed ID: 9713464
[TBL] [Abstract][Full Text] [Related]
17. A randomized double-blind trial to compare the clinical efficacy of granisetron with metoclopramide, both combined with dexamethasone in the prophylaxis of chemotherapy-induced delayed emesis.
Aapro MS; Thuerlimann B; Sessa C; De Pree C; Bernhard J; Maibach R;
Ann Oncol; 2003 Feb; 14(2):291-7. PubMed ID: 12562658
[TBL] [Abstract][Full Text] [Related]
18. Granisetron in the prevention of irradiation-induced emesis.
Prentice HG; Cunningham S; Gandhi L; Cunningham J; Collis C; Hamon MD
Bone Marrow Transplant; 1995 Mar; 15(3):445-8. PubMed ID: 7599570
[TBL] [Abstract][Full Text] [Related]
19. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
20. [Comparative trial of oral granisetron and intravenous ondansetron in patients receiving chemotherapy for breast cancer. Study Group of Granisetron].
Mabro M; Granisétron PK
Bull Cancer; 1999 Mar; 86(3):295-301. PubMed ID: 10210764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]